======= NPR2 ======= == Gene Information == * **Official Symbol**: NPR2 * **Official Name**: natriuretic peptide receptor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4882|4882]] * **UniProt**: [[https://www.uniprot.org/uniprot/P20594|P20594]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NPR2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NPR2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/108961|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes natriuretic peptide receptor B, one of two integral membrane receptors for natriuretic peptides. Both NPR1 and NPR2 contain five functional domains: an extracellular ligand-binding domain, a single membrane-spanning region, and intracellularly a protein kinase homology domain, a helical hinge region involved in oligomerization, and a carboxyl-terminal guanylyl cyclase catalytic domain. The protein is the primary receptor for C-type natriuretic peptide (CNP), which upon ligand binding exhibits greatly increased guanylyl cyclase activity. Mutations in this gene are the cause of acromesomelic dysplasia Maroteaux type. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |Pkinase| |Pkinase Tyr| |Guanylate cyc| |ANF receptor| |natriuretic peptide receptor activity| |negative regulation of oocyte maturation| |negative regulation of oocyte development| |negative regulation of oogenesis| |peptide receptor activity| |positive regulation of cGMP-mediated signaling| |regulation of oocyte maturation| |negative regulation of cell maturation| |guanylate cyclase activity| |response to granulocyte macrophage colony-stimulating factor| |cellular response to granulocyte macrophage colony-stimulating factor stimulus| |receptor guanylyl cyclase signaling pathway| |regulation of oocyte development| |regulation of oogenesis| |cGMP biosynthetic process| |hormone binding| |regulation of cGMP-mediated signaling| |negative regulation of meiotic cell cycle| |cGMP metabolic process| |cyclic nucleotide biosynthetic process| |cyclic purine nucleotide metabolic process| |regulation of cell maturation| |cGMP-mediated signaling| |peptide hormone binding| |cyclic nucleotide metabolic process| |regulation of meiotic cell cycle| |negative regulation of reproductive process| |regulation of cardiac conduction| |purine ribonucleotide biosynthetic process| |purine nucleotide biosynthetic process| |regulation of reproductive process| |ribonucleotide biosynthetic process| |ribose phosphate biosynthetic process| |purine-containing compound biosynthetic process| |cyclic-nucleotide-mediated signaling| |regulation of blood pressure| |bone development| |negative regulation of multi-organism process| |protein kinase activity| |regulation of heart contraction| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |ossification| |regulation of blood circulation| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |negative regulation of cell development| |ribose phosphate metabolic process| |second-messenger-mediated signaling| |purine-containing compound metabolic process| |GTP binding| |blood circulation| |circulatory system process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |skeletal system development| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |negative regulation of cell cycle| |regulation of system process| |carbohydrate derivative biosynthetic process| |negative regulation of cell differentiation| |enzyme linked receptor protein signaling pathway| |regulation of multi-organism process| |organophosphate metabolic process| |regulation of cell development| |negative regulation of developmental process| |protein phosphorylation| |cellular response to cytokine stimulus| |positive regulation of intracellular signal transduction| |carbohydrate derivative metabolic process| |identical protein binding| |nucleobase-containing compound biosynthetic process| |response to cytokine| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |negative regulation of multicellular organismal process| |phosphorylation| |organic cyclic compound biosynthetic process| |integral component of plasma membrane| |organonitrogen compound biosynthetic process| |reproductive process| |reproduction| |ATP binding| |cellular nitrogen compound biosynthetic process| |positive regulation of signal transduction| |intracellular signal transduction| |small molecule metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|-1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12323 * **Expression level (log2 read counts)**: 0.41 {{:chemogenomics:nalm6 dist.png?nolink |}}